There was a counteracting beneficial effect of L-arginine, and an opposite, additionally aggravating one of L-NAME, with their mutual counteraction
Ive been on Tirzepatide for a month now and lost 10 lb
Patients with T2DM, persons at risk for AD, had a significantly lower associated risk of AD after administered exenatide, liraglutide and dulaglutide ( Conclusion Increasing evidence suggests that anti-diabetes medicine, GLP-1R agonists, have multiple neuroprotective mechanisms in AD models, such as anti-inflammation, anti-oxidative stress, reducing A aggregation/deposition and tau protein hyperphosphorylation, reducing neuronal apoptosis and neurotoxicity, increasing cell proliferation and neurogenesis, increasing synaptic plasticity, and other beneficial effects
doi: 10.1038/s41421-021-00258-1 177 MagnaniH